UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.16%)
     
  • BTC-GBP

    24,205.12
    +641.77 (+2.72%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

An IVECO BUS Crossway belonging to the Italian Red Cross is the world's first high-biocontainment bus

·2-min read

IVECO GROUP N.V.

IVECO_BUS_Crossway_CRI_Altobiocontenimento_Credits Croce Rossa Italiana
IVECO_BUS_Crossway_CRI_Altobiocontenimento_Credits Croce Rossa Italiana
IVECO_BUS_Crossway_CRI_Altobiocontenimento_Credits Croce Rossa Italiana

Turin, 27th January 2022. The Italian Red Cross chose Crossway by IVECO BUS, a brand of Iveco Group (MI: IVG) and a leading manufacturer of buses and coaches, for its new high-biocontainment vehicle. The vehicle is a world first, capable of transporting up to 41 potentially infectious people plus 6 crew members, in total safety, within restricted areas like airports and to accommodation, hospital, and care facilities.

The IVECO BUS Crossway was chosen from the organisation's fleet and has already been used for urgent transport missions in Calabria. The 12-metre-long vehicle features the Cursor 9 engine from FPT Industrial, another global brand of Iveco Group that specialises in propulsion systems. The unique set-up includes a negative pressure chamber, which is a transparent envelope that surrounds the passenger compartment, where a difference in pressure from the outside prevents air from escaping unless it is filtered. The crew can monitor the pressure in the chamber, carbon dioxide saturation, temperature, and state of the filters using an integrated digital interface.

This special IVECO BUS Crossway, fitted out by the Italian Red Cross, is equipped with an electro-hydraulic wheelchair lift and has high comfort standards: air conditioning, night lighting, audio diffusion, tinted windows, and toilets inside the bio-containment chamber. The upholstery and interior have been covered with easily washable materials to ensure effective sanitisation.

"We are very proud that the Italian Red Cross has chosen one of the IVECO BUS flagship vehicles to create this special vehicle, the first in the world", commented Domenico Nucera, President, Bus Business Unit of Iveco Group. "At a time when the COVID-19 pandemic continues to spread through its variants, we are confident that this high-biocontainment vehicle will make an important contribution to reducing the risk of contamination, ensuring the safe transport of many patients".

Iveco Group N.V. (MI: IVG) is a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain, and related Financial Services arenas. Each of its eight brands is a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; Iveco Defence Vehicles, for highly-specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; Magirus, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs approximately 34,000 people around the world and has 29 manufacturing plants and 31 R&D centres. Further information is available on the Company’s website: www.ivecogroup.com

Media Contacts:
Francesco Polsinelli, Tel: +39 335 1776091
Fabio Lepore, Tel: +39 335 7469007

E-mail: mediarelations@ivecogroup.com

Attachments


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting